Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes. More info »
Generic Zetia is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet. It may be used alone or with other medicines. It is also used to treat high blood sitosterol and campesterol along with diet therapy. More info »
Yes! I have received the order and I am extremely
pleased with the service and the pills.
I had previously been paying a very high price through
prescriptions from my local GP.
I am now able to order online without hassle and
delivery has been within the stated period that you
give. Many thanks!
FDA rejects new indication for use of combination ezetimibe plus simvastatin ... - Cardiology Today
FDA rejects new indication for use of combination ezetimibe plus simvastatin .
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high ... - 7thSpace Interactive (press release)
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high .
FDA Rejects Proposed Chronic Kidney Disease Indication for Vytorin - Forbes
FDA Rejects Proposed Chronic Kidney Disease Indication for VytorinForbes25, 2012 – Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the US Food and Drug Administration (FDA) has approved an updated label for VYTORIN ® (ezetimibe/simvastatin) that includes results from the Study of .
Vytorin's label gets makeover to include SHARP results - Cardiovascular Business
Vytorin's label gets makeover to include SHARP resultsCardiovascular BusinessThe FDA has approved an updated label for Merck's Vytorin (ezetimibe/simvastatin) that includes results from the SHARP trial.
Entry Point for Hepatitis C Infection Identified - Biomed Middle East
Entry Point for Hepatitis C Infection IdentifiedBiomed Middle EastThe FDA-approved drug ezetimibe (sold under the trade-name Zetia) is readily available and perfectly targeted to the receptor, Sainz said, so the researchers had an ideal method for testing NPC1L1′s involvement in HCV infection.